Back | Next |
home / stock / avxl / avxl message board
Subject | By | Source | When |
---|---|---|---|
Excellent! Good to see a Pro recommendation. | williamssc | investorshub | 07/22/2024 7:41:02 PM |
His name sounded familiar. He was at | Doc328 | investorshub | 07/22/2024 7:30:42 PM |
Well, that has been proven to be true | sab63090 | investorshub | 07/22/2024 7:28:00 PM |
The successful bounce off of the 200 day | sab63090 | investorshub | 07/22/2024 7:25:38 PM |
Nice...always good to see well informed talented folks | nidan7500 | investorshub | 07/22/2024 7:10:03 PM |
Kolbert joined EF Hutton just a week ago. | rx7171 | investorshub | 07/22/2024 7:00:52 PM |
... and today's bounce brings price back into | 123tom | investorshub | 07/22/2024 6:43:27 PM |
I expect over 5 million shares to be | BDR10 | investorshub | 07/22/2024 6:30:57 PM |
LOL He is never on time. We need | mrplmer | investorshub | 07/22/2024 6:00:04 PM |
My hunch is a PR of attendance will | kevindenver | investorshub | 07/22/2024 5:25:21 PM |
Seems like a missed opportunity even just to | Jonjones325 | investorshub | 07/22/2024 5:05:57 PM |
It only has to be Pr'd if it | Steady_T | investorshub | 07/22/2024 4:51:19 PM |
Per regulation FD, new material info must be | kevindenver | investorshub | 07/22/2024 4:28:55 PM |
EFHutton brokers were absorbed into Morgan Stanley....just like | sab63090 | investorshub | 07/22/2024 4:07:09 PM |
Hmm! What was the commercial line for years | tredenwater2 | investorshub | 07/22/2024 3:43:48 PM |
I hope people listen... | tschussmann1 | investorshub | 07/22/2024 3:43:01 PM |
I thought E F Hutton went under | hnbadger1 | investorshub | 07/22/2024 3:37:48 PM |
Picked up a few more today. 🙂 | tschussmann1 | investorshub | 07/22/2024 3:34:30 PM |
I thought E F Hutton went under and, | boi568 | investorshub | 07/22/2024 3:30:25 PM |
EF Hutton Initiates Coverage On Anavex Life Sciences | RedShoulder | investorshub | 07/22/2024 3:16:24 PM |
News, Short Squeeze, Breakout and More Instantly...
Anavex Life Sciences Corp. Company Name:
AVXL Stock Symbol:
NASDAQ Market:
Anavex Life Sciences Corp. Website:
Oral, once daily blarcamesine significantly slowed clinical decline for early Alzheimer's disease patients with good comparative safety profile and no associated neuroimaging adverse events Clinical benefit of blarcamesine consistently observed for both 30 mg and 50 mg treatment groups ...
2024-07-18 02:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NEW YORK, June 20, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative, neurodevelopmental and neuropsyc...